[
  {
    "ts": null,
    "headline": "IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory",
    "summary": "We came across a bullish thesis on IDEXX Laboratories, Inc. on MTC’s Substack. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.’s share was trading at $643.59 as of February 5th. IDXX’s trailing and forward P/E were 49.20 and 45.25 respectively according to Yahoo Finance. IDEXX Laboratories, Inc. develops, manufactures, and distributes products […]",
    "url": "https://finnhub.io/api/news?id=7c8eb912587bb43a4e84eeefe36d59fff7d5e4bf65c07c266db9382bdaa43d00",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770480770,
      "headline": "IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory",
      "id": 138386641,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on IDEXX Laboratories, Inc. on MTC’s Substack. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.’s share was trading at $643.59 as of February 5th. IDXX’s trailing and forward P/E were 49.20 and 45.25 respectively according to Yahoo Finance. IDEXX Laboratories, Inc. develops, manufactures, and distributes products […]",
      "url": "https://finnhub.io/api/news?id=7c8eb912587bb43a4e84eeefe36d59fff7d5e4bf65c07c266db9382bdaa43d00"
    }
  }
]